302
Participants
Start Date
October 8, 2019
Primary Completion Date
March 23, 2020
Study Completion Date
March 23, 2020
AXS-07 (MoSEIC meloxicam and rizatriptan)
AXS-07 tablet taken once upon the earliest onset of migraine pain.
Placebo
Placebo tablet taken once upon the earliest onset of migraine pain.
Clinical Research Site, Manlius
Clinical Research Site, Williamsville
Clinical Research Site, Philadelphia
Clinical Research Site, Charlottesville
Clinical Research Site, High Point
Clinical Research Site, Charleston
Clinical Research Site, Mt. Pleasant
Clinical Research Site, Stockbridge
Clinical Research Site, Lake City
Clinical Research Site, Ormond Beach
Clinical Research Site, Jacksonville
Clinical Research Site, Orlando
Clinical Research Site, Hallandale
Clinical Research Site, South Miami
Clinical Research Site, Sunrise
Clinical Research Site, Lake Worth
Clinical Research Site, Tampa
Clinical Research Site, Ocoee
Clinical Research Site, Birmingham
Clinical Research Site, Birmingham
Clinical Research Site, Mobile
Clinical Research Site, Nashville
Clinical Research Site, Memphis
Clinical Research Site, Louisville
Clinical Research Site, Ann Arbor
Clinical Research Site, Evanston
Clinical Research Site, Springfield
Clinical Research Site, Oklahoma City
Clinical Research Site, Austin
Clinical Research Site, Salt Lake City
Clinical Research Site, Albuquerque
Clinical Research Site, Los Angeles
Clinical Research Site, Santa Monica
Clinical Research Site, Los Alamitos
Clinical Research Site, Encino
Clinical Research Site, Spring Valley
Clinical Research Site, Redlands
Clinical Research Site, Colton
Clinical Research Site, Walnut Creek
Clinical Research Site, Boston
Clinical Research Site, Waltham
Lead Sponsor
Axsome Therapeutics, Inc.
INDUSTRY